COH.AX COCHLEAR FPO [COH] | AU000000COH5
Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Latest News
Cloudbeds rolls out data intelligence tool for hotel groups
Hotel Management Network • 07/27/2026
KOC agrees $16bn pipeline deal with Blackstone, Brookfield, KKR
Offshore Technology • 07/27/2026
Meliá fully withdraws from Cuba amid economic crisis – report
Hotel Management Network • 07/27/2026
Man Group PLC : Form 8.3 - AMG Critical Materials N.V
GlobeNewswire • 07/27/2026
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.cochlear.com |
| Audit Risk | 2 |
| Board Risk | 1 |
| Overall Risk | 1 |
| Market Cap | 7.49B |
| Trailing P/E | 21.69 |
| Forward P/E | 22.19 |
| Dividend Rate | 4.3 |
| Dividend Yield | 3.85% |
| Trailing Annual Div. Rate | 4.3 |
| Trailing Annual Div. Yield | 3.85% |
| Trailing EPS | 5.28 |
| Forward EPS | 5.16 |
| Book Value | 29.63 |
| Price-to-Book | 3.86 |
| Enterprise-to-Revenue | 3.15 |
| Enterprise-to-EBITDA | 13.09 |
| Ex-Dividend Date | 03/19/2026 |
| Earnings Date | 08/18/2026 |
| Earnings Call Date |